Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Biopharma crawled date : 2022 - 10 - 25 save search
Aytu BioPharma Announces Agreement with Avenue Venture Debt Fund to Extend Interest-Only Period of Company's Term Loan
Published: 2022-10-25 (Crawled : 15:20) - biospace.com/
AYTU | $2.74 0.92% 0.91% 14K
|
Health Technology
|
| O: 0.44%
H: 10.63%
C: 6.25%
biopharma agreement
The 5 Most Affordable Cities for Biopharma Jobs in the US
Published: 2022-10-25 (Crawled : 15:00) - biospace.com/
NNBR | $3.825 -4.49% -4.71% 280K
|
Producer Manufacturing
|
| O: -1.91%
H: 6.34%
C: 5.85%
biopharma
Biopharma Veteran Ivor Macleod Joins SCYNEXIS as Chief Financial Officer
Published: 2022-10-25 (Crawled : 13:00) - globenewswire.com
SCYX | $1.495 -3.55% -3.68% 88K
|
Health Technology
|
| O: 0.0%
H: 6.75%
C: 5.41%
ATHX | $0.1018 -40.86% 95M
|
Health Technology
|
| O: -0.97%
H: 4.88%
C: -1.95%
biopharma financial
Immix Biopharma to Present Milestones Achieved to Enable Kick-Off of 2 IMX-110 Clinical Trials at the 2022 ThinkEquity Conference on October 26
Published: 2022-10-25 (Crawled : 12:00) - globenewswire.com
IMMX | $2.15 -6.52% -6.98% 60K
|
|
| O: 4.5%
H: 0.86%
C: -6.03%
imx-110 biopharma trials conference
Theravance Biopharma to Present New Ampreloxetine Data in Neurogenic Orthostatic Hypotension at the 33rd International Symposium on the Autonomic Nervous System
Published: 2022-10-25 (Crawled : 11:00) - biospace.com/
TBPH | $9.16 -0.65% -0.66% 300K
|
Health Technology
|
| O: 0.0%
H: 1.1%
C: -0.6%
biopharma system symposium international
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.